News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
540,649 Results
Type
Article (21832)
Company Profile (249)
Press Release (518564)
Multimedia
Podcasts (266)
Webinars (25)
Section
Business (183119)
Career Advice (1065)
Deals (28362)
Drug Delivery (149)
Drug Development (61400)
Employer Resources (149)
FDA (11076)
Job Trends (10475)
News (263500)
Policy (21020)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (23)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 NextGen (5)
2027 Pharm Country Digital (3)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (943)
Academic (1)
Accelerated approval (47)
ADA (27)
Adcomms (18)
Allergies (130)
Alliances (37459)
ALS (166)
Alzheimer's disease (1275)
Antibody-drug conjugate (ADC) (473)
Approvals (11539)
Artificial intelligence (651)
ASCO (214)
Autoimmune disease (349)
Automation (47)
Bankruptcy (305)
Belgium (14)
Best Places to Work (7572)
BIO (84)
Biologics (77)
BIOSECURE Act (17)
Biosimilars (179)
BioSpace Insights (261)
Biotechnology (142)
Bispecific (36)
Bladder cancer (164)
Brain cancer (51)
Breast cancer (613)
Cancer (4908)
Cardiovascular disease (374)
Career advice (948)
Career pathing (46)
CAR-T (289)
CDC (33)
CDMO (184)
Celiac Disease (4)
Cell-line development (2)
Cell therapy (805)
Cervical cancer (39)
Clinical research (54358)
Collaboration (1784)
Commercialization (49)
Company closure (8)
Compensation (1696)
Complete response letters (61)
COVID-19 (1927)
CRISPR (113)
CRO (5)
C-suite (1118)
Cystic fibrosis (109)
Data (7371)
Decentralized trials (3)
Denatured (112)
Depression (148)
Dermatology (109)
Diabetes (467)
Diagnostics (4785)
Digital health (47)
Diversity (12)
Diversity, equity & inclusion (41)
Drug discovery (320)
Drug pricing (99)
Drug shortages (16)
Duchenne muscular dystrophy (244)
Earnings (77412)
Editorial (58)
Employer branding (24)
Employer resources (125)
ESMO (285)
Events (96997)
Executive appointments (901)
Eye disease (13)
FDA (14271)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (2)
Friedreich's ataxia (26)
Frontotemporal dementia (30)
Funding (1505)
Gene editing (217)
Generative AI (58)
Gene therapy (626)
GLP-1 (734)
Government (1926)
Grass and pollen (3)
Guidances (301)
Healthcare (10466)
Hematology (134)
HIV (68)
Huntington's disease (54)
Idiopathic pulmonary fibrosis (9)
IgA nephropathy (106)
Immunology and inflammation (238)
Immuno-oncology (108)
Indications (202)
Infectious disease (2186)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (105)
Intellectual property (303)
Interviews (174)
IPO (13260)
IRA (27)
Job creations (3008)
Job search strategy (816)
JPM (61)
Kidney cancer (19)
Kidney disease (109)
Labor market (144)
Layoffs (392)
Leadership (34)
Legal (5875)
Licensing (82)
Liver cancer (68)
Longevity (40)
Lung cancer (706)
Lung diease (17)
Lymphoma (313)
Machine learning (50)
Management (37)
Manufacturing (1004)
Marketing (26)
MASH (176)
Medical affairs (2)
Medical device (9168)
Medtech (9383)
Mergers & acquisitions (16297)
Metabolic disorders (1195)
Middle East (2)
mRNA (260)
Multiple sclerosis (138)
Multispecific (5)
NASH (12)
Netherlands (9)
Neurodegenerative disease (370)
Neuropsychiatric disorders (76)
Neuroscience (2531)
Neurotech (3)
NextGen: Class of 2026 (3981)
Non-profit (1079)
Now hiring (92)
Obesity (498)
Opinion (215)
Ovarian cancer (204)
Pain (217)
Pancreatic cancer (279)
Parkinson's disease (258)
Partnered (42)
Patents (595)
Patient advocacy (4)
Patient recruitment (621)
Patient selection (64)
Peanut (38)
People (46364)
Peptides (29)
Pharmaceutical (44)
Pharmacy benefit managers (19)
Phase 1 (17650)
Phase 2 (24514)
Phase 3 (17060)
Pipeline (9980)
Policy (251)
Postmarket research (1669)
Preclinical (7423)
Press Release (49)
Prostate cancer (234)
Psychedelics (70)
Radioligand (2)
Radiopharmaceuticals (266)
Rare diseases (984)
Real estate (3920)
Recruiting (56)
Regenerative medicine (23)
Regulatory (17656)
Reports (88)
Research institute (983)
Resumes & cover letters (155)
Rett syndrome (52)
RNA editing (28)
RSV (61)
Saudi Arabia (1)
Schizophrenia (137)
Series A (298)
Series B (202)
Service/supplier (6)
Sickle cell disease (91)
Special edition (36)
Spinal muscular atrophy (111)
Sponsored (35)
Startups (2898)
State (1)
Stem cells (6)
Stomach cancer (7)
Substance use disorders (21)
Supply chain (89)
Switzerland (6)
Tariffs (35)
Tax incentives (2)
The Weekly (151)
Vaccines (886)
Venture capital (145)
Weight loss (282)
Wet AMD (4)
Women's health (129)
Women in leadership (1)
Worklife (22)
Date
Today (169)
Last 7 days (699)
Last 30 days (2710)
Last 365 days (22238)
2026 (20121)
2025 (21831)
2024 (25950)
2023 (29613)
2022 (38616)
2021 (41005)
2020 (36502)
2019 (26110)
2018 (19578)
2017 (21980)
2016 (21354)
2015 (26995)
2014 (23783)
2013 (19816)
2012 (21881)
2011 (22022)
2010 (21652)
Location
Africa (520)
Alabama (86)
Alaska (2)
Arizona (343)
Arkansas (13)
Asia (24704)
Australia (3155)
California (14285)
Canada (3636)
China (974)
Colorado (578)
Connecticut (512)
Delaware (301)
Europe (38035)
Florida (2060)
Georgia (434)
Hawaii (4)
Idaho (51)
Illinois (926)
India (93)
Indiana (373)
Iowa (23)
Japan (509)
Kansas (120)
Kentucky (39)
Louisiana (36)
Maine (28)
Maryland (1414)
Massachusetts (9544)
Michigan (339)
Minnesota (704)
Mississippi (6)
Missouri (97)
Montana (21)
Nebraska (14)
Nevada (177)
New Hampshire (71)
New Jersey (3118)
New Mexico (22)
New York (3311)
North Carolina (1527)
North Dakota (5)
Northern California (7272)
Ohio (368)
Oklahoma (17)
Oregon (23)
Pennsylvania (2642)
Puerto Rico (28)
Rhode Island (41)
South America (682)
South Carolina (85)
South Dakota (1)
Southern California (5855)
Tennessee (142)
Texas (2402)
United States (46320)
Utah (461)
Vermont (1)
Virginia (192)
Washington D.C. (53)
Washington State (1076)
West Virginia (2)
Wisconsin (92)
Wyoming (1)
540,649 Results for "treos bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TREOS Bio Appoints Sunjeet Sawhney as Chief Executive Officer
May 28, 2026
·
3 min read
Press Releases
Treos Bio Presents New Translational Data Showing PolyPEPI1018 Plus Anti-PD-L1 Immunotherapy Remodels the Tumor Immune Microenvironment in MSS Colorectal Cancer
July 2, 2026
·
3 min read
Press Releases
TREOS Bio Presents New PEPI Technology Data at EACR 2026, Including Six-Year Cancer-Free Outcome in MSS Metastatic Colorectal Cancer (mCRC)
June 9, 2026
·
5 min read
Drug Development
Dren Bio lands $350M to push rare blood cancer therapy toward market
After Sanofi paid $600 million in cash to acquire Dren Bio’s bispecific last year, the biotech has secured a hefty financing to fund late-stage development and commercial preparations for its lead asset.
October 29, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
TREOS Bio Announces Publication of Phase 1b Clinical Trial Results of PolyPEPI1018 Plus TAS-102 in Refractory MSS mCRC in JCO Oncology Advances
November 6, 2025
·
3 min read
China
BIO pitches US plan to beat China in biotech ‘space race’
The seven proposals in the Bio Advance plan include easing clinical trial starts, boosting manufacturing and establishing a new White House office to coordinate the government’s biotech policy.
November 10, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer
August 28, 2025
·
3 min read
Press Releases
Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
November 1, 2026
·
5 min read
Press Releases
INmune Bio Inc. Announces Third Quarter 2026 Results and Provides Business Update
November 6, 2026
·
13 min read
Funding
BrainChild Bio targets deadly pediatric brain cancer with $116M series A
BrainChild Bio’s lead asset BCB-276 is in pivotal development for diffuse intrinsic pontine glioma, a rare and fatal brain tumor that affects around 300 children in the U.S. every year.
September 8, 2026
·
2 min read
·
Tristan Manalac
1 of 54,065
Next